| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $299.2M | +21.5% |
| SG&A Expense | $196.0M | +0.7% |
| Operating Income | -$506.8M | -12.6% |
| Pre-tax Income | -$487.7M | -40.6% |
| Income Tax | $0 | — |
| Net Income | -$487.7M | -40.6% |
| EPS (Basic) | -$1.81 | -19.1% |
| EPS (Diluted) | -$1.81 | -19.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.6M | -83.7% |
| Inventory | $3.0M | — |
| Current Assets | $52.3M | -82.0% |
| Total Assets | $496.5M | -5.1% |
| Current Liabilities | $218.3M | +60.3% |
| Total Liabilities | $259.9M | +45.1% |
| Stockholders' Equity | $236.6M | -31.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$400.5M | -33.1% |
| Capital Expenditures | $97.3M | -28.8% |
| Investing Cash Flow | -$66.8M | +58.9% |
| Financing Cash Flow | $290.4M | +2650.7% |
| Free Cash Flow | -$497.7M | -13.8% |